Prevalence and molecular epidemiology of ceftaroline non-susceptible methicillin-resistant Staphylococcus aureus isolates, first clinical report from Iran.
Amin KhoshbayanAref ShariatiEhsanollah Ghaznavi-RadAlex van BelkumDavood Darban-SarokhalilPublished in: Acta microbiologica et immunologica Hungarica (2020)
Due to the broad-spectrum activity and low toxicity of ceftaroline as well as the increased rate of vancomycin resistance among MRSA strains in recent years, ceftaroline can be considered as a novel approach to treat MRSA-induced infections.